Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

BACKGROUND: The relevance of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC) is largely unknown. Clinical trials targeting ER with selective estrogen receptor modulators in pancreatic cancer did not show any benefit. Here, we analyze the impact of recently characterized...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Seeliger, Hendrik, Pozios, Ioannis, Assmann, Gerald, Zhao, Yue, Müller, Mario H., Knösel, Thomas, Kreis, Martin E., Bruns, Christiane J.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206939/
https://ncbi.nlm.nih.gov/pubmed/30373552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4973-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars